Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07075705 · ClinicalTrials.gov registry record · NA
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
A NA study, sponsored by Roswell Park Cancer Institute.
- Not yet
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT07075705 is a NA study that has not yet begun recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 138 participants.
The verdict
NCT07075705, a NA study, has not yet begun recruiting, sponsored by Roswell Park Cancer Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
This clinical trial studies whether transperineal micro-ultrasound can be used to detect prostate cancer during biopsy. Transrectal ultrasound is often used during prostate biopsy. Transrectal ultrasound imaging is a procedure in which a probe that sends out high-energy sound waves is inserted into the rectum. The sound waves are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissue called a sonogram. Transrectal ultrasound is used to look for abnormalities in the rectum and nearby structures, including the prostate. The images are used to guide the prostate biopsy. Transperineal micro-ultrasound is completed by placing a probe over the skin between the scrotum and anus (perineum). It is a high-resolution ultrasound at 29 megahertz (MHz) (compared to traditional ultrasound at 6-9 MHz). This higher frequency allows for an improved spatial resolution. This improved spatial resolution is approximately the diameter of a prostatic duct, and therefore, may be able to visualize slight changes in the structure of prostatic ducts that are not possible with standard transrectal ultrasound. Transperineal micro-ultrasound may be more effective in detecting prostate cancer during biopsy.
Interventions
- PROCEDURE Magnetic Resonance Imaging
- PROCEDURE Biopsy of Prostate
- PROCEDURE Micro-ultrasound Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07075705
The ClinicalTrials.gov registry entry for NCT07075705 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT07075705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07075705 about?
NCT07075705 is a clinical study titled "Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy". This clinical trial studies whether transperineal micro-ultrasound can be used to detect prostate cancer during biopsy. Transrectal ultrasound is often used during prostate biopsy. Transrectal ultrasound imaging is a procedure in which a probe that sends out high-energy sound waves is inserted into ...
What is the current status of trial NCT07075705?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 138 participants. The study started on 2026-07-15. Estimated completion is 2027-01-15.
What interventions are being tested in trial NCT07075705?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Biopsy of Prostate (PROCEDURE), Micro-ultrasound Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT07075705?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.